Funded Startups in Concord
Across the 25 most recent funding entries shown for Concord, the disclosed amounts cluster heavily in the single-digit to tens-of-millions range, but one o…
Across the 25 most recent funding entries shown for Concord, the disclosed amounts cluster heavily in the single-digit to tens-of-millions range, but one outlier stands out: Insurance Supermarket raised $100M on 2022-07-18 (Private Equity), far above the next-largest disclosed rounds such as Honor’s $300M debt financing on 2021-10-05 and Comanche Biopharma’s $75M on 2024-01-17. Another clear split appears in stage and disclosure: 11 of 25 rows are “undisclosed” or “Series Unknown” (including “undisclosed” amounts and blank/unknown series), while disclosed amounts range from $1M (e.g., Issio Solutions on 2025-07-22 and Lennham Pharmaceuticals on 2023-04-03) up to $300M (Honor, 2021-10-05).
Geographically, the Concord label is not uniform: Concord, Massachusetts dominates the list (including multiple large disclosed rounds like Comanche Biopharma’s $75M on 2024-01-17 and Culture POP Soda’s $21M on 2024-02-09), with additional entries in Concord, California; Concord, Michigan; Concord, North Carolina; and even Concord, Ontario and Concord, New Hampshire. Temporally, the rows span 2020-09-15 (Volansi) to 2026-04-22 (Ability Central), with the newest wave concentrated in 2026 and late 2025 (e.g., TESS on 2026-03-02 and Corista on 2025-12-02).
Most recent rounds
25 shownRelated listings
Frequently asked
Which disclosed rounds are outliers versus the rest of the Concord list, and where do they land in the range?
The highest disclosed amount is Honor’s $300M debt financing on 2021-10-05, and Insurance Supermarket’s $100M private equity round on 2022-07-18 is another major outlier. The next tier is still large but much lower, including Comanche Biopharma’s $75M (2024-01-17) and Culture POP Soda’s $21M (2024-02-09).
How concentrated are the entries by geography when the city name is “Concord”?
Concord, Massachusetts accounts for multiple entries and several high disclosed amounts, including Comanche Biopharma ($75M on 2024-01-17), Culture POP Soda ($21M on 2024-02-09), and Talkmap ($8M on 2022-02-01). Other Concords appear with fewer entries, such as Concord, California (e.g., Honor’s California entry is debt financing on 2021-10-05; TESS is in Concord, California with $5M on 2026-03-02) and Concord, Ontario (Insurance Supermarket $100M on 2022-07-18).
What does the “recent” window look like when restricting attention to the newest close dates shown?
Within the most recent entries shown, 2026 contains multiple rounds that include disclosed amounts like TESS ($5M on 2026-03-02) and earlier 2025 entries like Corista ($13M on 2025-12-02) and Cristcot ($11M on 2025-06-06). The date span for these displayed rows runs from 2020-09-15 (Volansi) through 2026-04-22 (Ability Central).
Is there a sector cluster, and how does that cluster relate to disclosure patterns?
Health Care appears repeatedly across different Concords, including Corista ($13M on 2025-12-02 in Concord, Massachusetts), Cristcot ($11M on 2025-06-06 in Concord, Massachusetts), and Honor (Debt Financing, $300M on 2021-10-05 in Concord, California). At the same time, a sizable share of rows are “undisclosed” or “Series Unknown” (11 of 25), such as Ability Central (2026-04-22, undisclosed) and Bolt (2024-01-17, undisclosed).
Where do the smallest disclosed rounds sit, and do they occur alongside large raises in the same time or location?
The smallest disclosed amount in the shown data is $1M, appearing for Issio Solutions on 2025-07-22 (Concord, California) and Lennham Pharmaceuticals on 2023-04-03 (Concord, Massachusetts). Those low disclosed rounds coexist with very large disclosed financing in the same overall Concord listing, including Honor’s $300M (2021-10-05) and Insurance Supermarket’s $100M (2022-07-18).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.